Follow
Victor Talisa
Victor Talisa
Dept. of Biostatistics, Univ. of Pittsburgh
Verified email at pitt.edu
Title
Cited by
Cited by
Year
Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis
CW Seymour, JN Kennedy, S Wang, CCH Chang, CF Elliott, Z Xu, S Berry, ...
Jama 321 (20), 2003-2017, 2019
11412019
Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions
FB Mayr, VB Talisa, V Balakumar, CCH Chang, M Fine, S Yende
JAMA, 2017
1802017
Long-term host immune response trajectories among hospitalized patients with sepsis
S Yende, JA Kellum, VB Talisa, OMP Palmer, CCH Chang, MR Filbin, ...
JAMA network open 2 (8), e198686-e198686, 2019
1462019
Sepsis Subclasses: A Framework for Development and Interpretation.
KM DeMerle, DC Angus, JK Baillie, E Brant, CS Calfee, J Carcillo, ...
Critical care medicine, 2021
1332021
Exercise, manual therapy, and use of booster sessions in physical therapy for knee osteoarthritis: a multi-center, factorial randomized clinical trial
GK Fitzgerald, JM Fritz, JD Childs, GP Brennan, V Talisa, AB Gil, ...
Osteoarthritis and cartilage 24 (8), 1340-1349, 2016
932016
Children with chronic disease bear the highest burden of pediatric sepsis
AJ Prout, VB Talisa, JA Carcillo, FB Mayr, DC Angus, CW Seymour, ...
The Journal of pediatrics 199, 194-199. e1, 2018
732018
Effectiveness of homologous or heterologous Covid-19 boosters in veterans
FB Mayr, VB Talisa, O Shaikh, S Yende, AA Butt
New England Journal of Medicine 386 (14), 1375-1377, 2022
702022
Autism and anxiety in males with fragile X syndrome: An exploratory analysis of neurobehavioral profiles from a parent survey
VB Talisa, L Boyle, D Crafa, WE Kaufmann
American Journal of Medical Genetics Part A 164 (5), 1198-1203, 2014
702014
Parental reports on early language and motor milestones in fragile X syndrome with and without autism spectrum disorders
R Hinton, DB Budimirovic, PB Marschik, VB Talisa, C Einspieler, T Gipson, ...
Developmental neurorehabilitation 16 (1), 58-66, 2013
542013
Arguing for adaptive clinical trials in sepsis
VB Talisa, S Yende, CW Seymour, DC Angus
Frontiers in immunology 9, 1502, 2018
462018
COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
FB Mayr, VB Talisa, AD Castro, OS Shaikh, SB Omer, AA Butt
Nature communications 13 (1), 1-6, 2022
422022
Intra-uterine exposure to maternal opiate abuse and HIV: The impact on the developing nervous system
AB Palchik, C Einspieler, IV Evstafeyeva, VB Talisa, PB Marschik
Early human development 89 (4), 229-235, 2013
362013
Peculiarities in the gestural repertoire: An early marker for Rett syndrome?
PB Marschik, J Sigafoos, WE Kaufmann, T Wolin, VB Talisa, ...
Research in developmental disabilities 33 (6), 1715-1721, 2012
322012
Estimating the Impact of Necrotizing Soft Tissue Infections in the United States: Incidence and Re-Admissions
AK May, VB Talisa, DA Wilfret, E Bulger, W Dankner, A Bernard, S Yende
Surgical Infections, 2020
292020
Relative vaccine effectiveness of a SARS-CoV-2 mRNA vaccine booster dose against the Omicron variant.
AA Butt, VB Talisa, OS Shaikh, SB Omer, FB Mayr
Clinical Infectious Diseases: an Official Publication of the Infectious …, 2022
282022
Bacterial and Fungal Etiology of Sepsis in Children in the United States: Reconsidering Empiric Therapy
AJ Prout, VB Talisa, JA Carcillo, BK Decker, S Yende
Critical Care Medicine, 2020
272020
Relative vaccine effectiveness of a severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine booster dose against the Omicron variant
AA Butt, VB Talisa, OS Shaikh, SB Omer, FB Mayr
Clinical Infectious Diseases, 2022
252022
Epidemiology of readmissions after sepsis hospitalization in children
AJ Prout, VB Talisa, JA Carcillo, DC Angus, CCH Chang, S Yende
Hospital pediatrics 9 (4), 249-255, 2019
202019
Comparative COVID-19 Vaccine Effectiveness Over Time in Veterans
FB Mayr, VB Talisa, OS Shaikh, SB Omer, AA Butt, S Yende
Open forum infectious diseases 9 (7), ofac311, 2022
162022
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population
AA Butt, VB Talisa, P Yan, OS Shaikh, SB Omer, FB Mayr
Clinical Infectious Diseases, 2022
152022
The system can't perform the operation now. Try again later.
Articles 1–20